PIK3CA and cerebral cavernous malformation: Despite the finding that many CCM patients also bear activating mutations in PIK3CA, it remains an open question whether an activating oncogenic mutation is required for lesion formation in human patients, or whether, as in mice, another growth stimulus could play the same role.